As of 2024-07-27, the Intrinsic Value of Johnson & Johnson (JNJ) is
175.79 USD. This JNJ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 160.64 USD, the upside of Johnson & Johnson is
%.
The range of the Intrinsic Value is 116.39 - 360.37 USD
175.79 USD
Intrinsic Value
JNJ Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
116.39 - 360.37 |
175.79 |
9.4% |
| DCF (Growth 10y) |
133.56 - 382.00 |
194.48 |
21.1% |
| DCF (EBITDA 5y) |
79.53 - 158.85 |
103.94 |
-35.3% |
| DCF (EBITDA 10y) |
101.67 - 188.59 |
129.02 |
-19.7% |
| Fair Value |
378.87 - 378.87 |
378.87 |
135.85% |
| P/E |
134.40 - 532.67 |
328.48 |
104.5% |
| EV/EBITDA |
95.20 - 211.45 |
154.10 |
-4.1% |
| EPV |
106.07 - 145.38 |
125.73 |
-21.7% |
| DDM - Stable |
180.78 - 715.94 |
448.36 |
179.1% |
| DDM - Multi |
98.66 - 295.10 |
146.86 |
-8.6% |
JNJ Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
386,609.06 |
| Beta |
0.48 |
| Outstanding shares (mil) |
2,406.68 |
| Enterprise Value (mil) |
413,009.06 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.05% |
| Cost of Debt |
5.22% |
| WACC |
6.87% |